Partner Greg Husisian is quoted in a Forbes article, “Game Changer in NAFTA as Trump Makes Mexican Border A Potential Deal Breaker,” about the chances that a NAFTA deal will be struck prior to Mexico’s July 1 presidential election.
Husisian views President Trump’s threats to pull out of NAFTA over the issue of border security as a tactic designed to apply leverage in the trade talks.
“I see no chance of this getting wrapped up by July 1, let alone May 1 (the deadline Trump has set for a trade deal in exchange for a temporary exemption from his proposed tariffs on aluminum and steel),” Husisian said. “This is an important trade deal for Mexico. [Leading presidential candidate Andres Manuel Lopez] Obrador can talk all he wants about more trade with China or whatever. But if NAFTA dies, the whole Mexican economy takes a hit. They are really limited on how much they can stick it to the U.S. in these negotiations.”
Husisian views President Trump’s threats to pull out of NAFTA over the issue of border security as a tactic designed to apply leverage in the trade talks.
“I see no chance of this getting wrapped up by July 1, let alone May 1 (the deadline Trump has set for a trade deal in exchange for a temporary exemption from his proposed tariffs on aluminum and steel),” Husisian said. “This is an important trade deal for Mexico. [Leading presidential candidate Andres Manuel Lopez] Obrador can talk all he wants about more trade with China or whatever. But if NAFTA dies, the whole Mexican economy takes a hit. They are really limited on how much they can stick it to the U.S. in these negotiations.”
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."